IgM paraproteinemia in a patient with primary lateral sclerosis

Neuromuscular Disorders

Volumn 9, Issue 1, 1999, Pages 38-40

  Desai, Joy ^a   Swash, Michael ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

IgM paraproteinemia; Lymphoproliferative disorders; Motor neuron diseases; Primary lateral sclerosis; Pyramidal tract involvement

Indexed keywords

CHLORAMBUCIL; IMMUNOGLOBULIN M; PREDNISOLONE;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MUSCLE STRENGTH; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SPASTICITY; TENDON REFLEX; TREATMENT OUTCOME;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD SEDIMENTATION; CEREBROSPINAL FLUID PROTEINS; ELECTROMYOGRAPHY; HUMANS; IMMUNOGLOBULIN M; MALE; PARAPROTEINEMIAS; PARAPROTEINS;

EID: 0032997669     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00089-3     Document Type: Article

References (13)

1. Younger DS, Chou S, Hays AP. Primary lateral sclerosis: a clinical diagnosis re-emerges. Arch Neurol 1988;45:1304-1307.
2. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992;115:495-520.
3. Gordon PH, Rowland LP, Younger DS, et al. Lymphoproliferative disorders and motor neuron disease: an update. Neurology 1997; 48:1671-1678.
4. Leone KV, Phillips LH. Lymphoproliferative disorders and motor neuron disease. To the editor. Neurology 1998;50:576.
5. Kelly JJ. Polyneuropathies associated with plasma cell dyscrasias. Semin Neurol 1987;7:30.
6. Zifko U, Drlicek M, Machacek E, Jellinger K, Grisold W. Syndrome of continuous muscle fibre activity and plasmacytoma with IgM paraproteinemia. Neurology 1994;44:560-561.
7. Rowland LP, Sherman WL, Hays AP, et al. Autopsy-proven amyotrophic lateral sclerosis, Waldenstrom's macroglobulinemia and antibodies to sulphated glucuronic acid paragloboside. Neurology 1995;45:827-829.
8. Younger DS, Rowland LP, Latov N, et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990;40:595-599.
9. Younger DS, Rowland LP, Latov N, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 1991;29:78-86.
10. Axelsson U, Bachmann R, Hallen J. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 1966;179:235-247.
11. Brownell B, Trevor-Hughes J. Central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338-357.
12. Adams D, Said G. Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome. J Neurol Neurosurg Psychiatry 1998;64:809-812.
13. Hiemstra PS, Biewenga J, Corter A, et al. Activation of complement by human serum IgA, secretory IgA, and IgAl fragments. Mol Immunol 1988;25:527-533.